Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-24-061321

Director sold 22,489 shares at an average $212.88 ($4,787,404)

  • Director acquired 22,489 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CRAVES FRED B Director 2024-05-14 Option exercise 10b5-1 +10,000 $100.45 $1,004,500 423,362 D
CRAVES FRED B Director 2024-05-14 Option exercise 10b5-1 +12,489 $105.08 $1,312,344 435,851 D
CRAVES FRED B Director 2024-05-14 Sale 10b5-1 −8,827 $210.99 $1,862,432 427,024 D
CRAVES FRED B Director 2024-05-14 Sale 10b5-1 −5,009 $211.84 $1,061,127 422,015 D
CRAVES FRED B Director 2024-05-14 Sale 10b5-1 −1,363 $212.85 $290,116 420,652 D
CRAVES FRED B Director 2024-05-14 Sale 10b5-1 −2,190 $213.85 $468,342 418,462 D
CRAVES FRED B Director 2024-05-14 Sale 10b5-1 −1,804 $214.68 $387,285 416,658 D
CRAVES FRED B Director 2024-05-14 Sale 10b5-1 −375 $216.08 $81,031 416,283 D
CRAVES FRED B Director 2024-05-14 Sale 10b5-1 −721 $216.98 $156,445 415,562 D
CRAVES FRED B Director 2024-05-14 Sale 10b5-1 −1,100 $217.86 $239,641 414,462 D
CRAVES FRED B Director 2024-05-14 Sale 10b5-1 −1,000 $218.99 $218,995 413,462 D
CRAVES FRED B Director 2024-05-14 Sale 10b5-1 −100 $219.90 $21,990 413,362 D
Derivatives
CRAVES FRED B Director 2024-05-14 Option exercise · Stock Option (right to buy) 10b5-1 −10,000 0 D
CRAVES FRED B Director 2024-05-14 Option exercise · Stock Option (right to buy) 10b5-1 −12,489 0 D
Open-market sales · 22,489 sh · avg $212.88 · $4,787,404
Loading xslF345X05/ownership.xml…